Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence that human cardiac allograft acceptance is associated with a decrease in donor-reactive helper T lymphocytes

L A DeBruyne1, D G Renlund, D K Bishop

  • 1Department of Surgery, University of Michigan School of Medicine, Ann Arbor 48109.

Transplantation
|March 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of cardiac allograft rejection by T lymphocytes.

Trends in cardiovascular medicine·2011
Same author

Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006

Monitoring donor-reactive helper T lymphocytes (HTL) can predict cardiac allograft acceptance. Reduced HTL numbers in long-term acceptors suggest potential for reduced immunosuppression, while high HTL levels indicate persistent rejection.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Cellular Biology

Background:

  • Acute cardiac allograft rejection is linked to increased donor-reactive helper T lymphocytes (HTL).
  • Elevated HTL frequencies may predict rejection episodes diagnosed via endomyocardial biopsy.

Purpose of the Study:

  • To evaluate the association between donor-reactive HTL and allograft acceptance in long-term cardiac transplant recipients (>1 year).
  • To determine if monitoring HTL can identify patients suitable for reduced immunosuppression.

Main Methods:

  • Categorization of patients into long-term acceptors or persistent rejecters based on rejection history and steroid withdrawal.
  • Limiting dilution analysis for IL-2-producing HTL using donor splenocytes.
  • Quantification of donor-reactive HTL frequencies in peripheral blood pre-transplant, and at 1 month and 1 year post-transplant.

Related Experiment Videos

Main Results:

  • Long-term acceptors showed reduced donor-reactive HTL at 1 year post-transplant and weak responses in mixed lymphocyte response (MLR).
  • A case study demonstrated that IL-2 deficiency, not HTL absence, caused nonresponsiveness in an immunosuppression-withdrawn patient.
  • Persistent rejecters maintained high donor-reactive HTL levels and vigorous MLR responses at 1 year post-transplant.

Conclusions:

  • Reduced donor-reactive HTL frequencies correlate with successful allograft accommodation and potential for immunosuppression reduction.
  • Monitoring donor-reactive HTL may serve as a biomarker to identify patients who can tolerate decreased immunosuppressive therapy.
  • Deficits in IL-2 production, rather than complete HTL absence, may underlie graft tolerance in specific cases.